Susquehanna International Group, LLP Sarepta Therapeutics, Inc. Call Options Transaction History

Susquehanna International Group, LLP

$560 Billion
Q3 2024

Call Options

29 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	SELL	$124.33 - $156.75 $20.5 Million - $25.8 Million	-164,600 Reduced 27.38%	436,600 $54.5 Million
Q2 2024 Aug 15, 2024	SELL	$113.33 - $163.85 $12.6 Million - $18.3 Million	-111,400 Reduced 15.63%	601,200 $95 Million
Q1 2024 May 07, 2024	SELL	$93.7 - $141.53 $17.6 Million - $26.6 Million	-188,200 Reduced 20.89%	712,600 $92.3 Million
Q4 2023 Feb 14, 2024	BUY	$67.31 - $124.76 $25.3 Million - $47 Million	376,500 Added 71.81%	900,800 $86.9 Million
Q3 2023 Nov 14, 2023	SELL	$102.5 - $123.59 $1.77 Million - $2.14 Million	-17,300 Reduced 3.19%	524,300 $63.6 Million
Q2 2023 Aug 11, 2023	BUY	$106.4 - $157.19 $2.66 Million - $3.93 Million	25,000 Added 4.84%	541,600 $62 Million
Q1 2023 May 16, 2023	BUY	$117.53 - $155.99 $17.1 Million - $22.7 Million	145,600 Added 39.25%	516,600 $71.2 Million
Q4 2022 Feb 14, 2023	BUY	$100.86 - $132.13 $3.35 Million - $4.39 Million	33,200 Added 9.83%	371,000 $48.1 Million
Q3 2022 Nov 14, 2022	SELL	$75.71 - $119.24 $522,398 - $822,756	-6,900 Reduced 2.0%	337,800 $37.3 Million
Q2 2022 Aug 15, 2022	SELL	$62.69 - $88.44 $3.71 Million - $5.24 Million	-59,200 Reduced 14.66%	344,700 $25.8 Million
Q1 2022 May 16, 2022	BUY	$63.15 - $90.42 $5.89 Million - $8.43 Million	93,200 Added 30.0%	403,900 $31.6 Million
Q4 2021 Feb 14, 2022	BUY	$77.28 - $99.42 $1.86 Million - $2.4 Million	24,100 Added 8.41%	310,700 $28 Million
Q3 2021 Nov 15, 2021	SELL	$65.97 - $92.48 $3.97 Million - $5.57 Million	-60,200 Reduced 17.36%	286,600 $26.5 Million
Q2 2021 Aug 11, 2021	BUY	$69.38 - $86.75 $3.35 Million - $4.19 Million	48,300 Added 16.18%	346,800 $27 Million
Q1 2021 May 17, 2021	SELL	$72.25 - $168.95 $22.4 Million - $52.4 Million	-310,200 Reduced 50.96%	298,500 $22.2 Million
Q4 2020 Feb 16, 2021	SELL	$125.56 - $178.74 $5.37 Million - $7.65 Million	-42,800 Reduced 6.57%	608,700 $104 Million
Q3 2020 Nov 16, 2020	SELL	$127.12 - $172.34 $5.54 Million - $7.51 Million	-43,600 Reduced 6.27%	651,500 $91.5 Million
Q2 2020 Aug 14, 2020	BUY	$93.0 - $171.7 $35.9 Million - $66.3 Million	386,300 Added 125.1%	695,100 $111 Million
Q1 2020 May 15, 2020	SELL	$82.38 - $131.64 $87.3 Million - $139 Million	-1,059,600 Reduced 77.43%	308,800 $30.2 Million
Q4 2019 Feb 14, 2020	BUY	$76.53 - $135.58 $25.4 Million - $45.1 Million	332,400 Added 32.08%	1,368,400 $177 Million
Q3 2019 Nov 14, 2019	BUY	$72.81 - $156.91 $6.31 Million - $13.6 Million	86,700 Added 9.13%	1,036,000 $78 Million
Q2 2019 Aug 14, 2019	BUY	$112.21 - $151.95 $7.65 Million - $10.4 Million	68,200 Added 7.74%	949,300 $144 Million
Q1 2019 May 15, 2019	BUY	$106.67 - $151.68 $32.3 Million - $46 Million	303,100 Added 52.44%	881,100 $105 Million
Q4 2018 Feb 14, 2019	SELL	$97.32 - $148.76 $43.2 Million - $66 Million	-443,800 Reduced 43.43%	578,000 $63.1 Million
Q3 2018 Nov 14, 2018	BUY	$115.31 - $161.51 $6.58 Million - $9.22 Million	57,100 Added 5.92%	1,021,800 $165 Million
Q2 2018 Aug 14, 2018	BUY	$71.74 - $153.69 $7.2 Million - $15.4 Million	100,400 Added 11.62%	964,700 $128 Million
Q1 2018 May 15, 2018	SELL	$54.02 - $82.27 $62.4 Million - $95.1 Million	-1,155,400 Reduced 57.21%	864,300 $64 Million
Q4 2017 Feb 14, 2018	BUY	$47.64 - $56.75 $42.2 Million - $50.2 Million	884,900 Added 77.98%	2,019,700 $112 Million
Q3 2017 Nov 14, 2017	BUY	$35.73 - $47.15 $40.5 Million - $53.5 Million	1,134,800	1,134,800 $51.5 Million

Others Institutions Holding SRPT

# of Institutions

532

Shares Held

84.5M

Call Options Held

2.06M

Put Options Held

1.52M

Black Rock Inc. New York, NY

10.3M
Shares

$1.08 Billion
0.04% of portfolio
Vanguard Group Inc Valley Forge, PA

8.97M
Shares

$937 Million
0.02% of portfolio
Capital International Investors Los Angeles, CA

6.26M
Shares

$654 Million
0.16% of portfolio
Janus Henderson Group PLC London, X0

4.36M
Shares

$456 Million
0.29% of portfolio
State Street Corp Boston, MA

4.27M
Shares

$446 Million
0.02% of portfolio

View Full List

About Sarepta Therapeutics, Inc.

Ticker SRPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,567,904
Market Cap $9.15B
Description
Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...

More about SRPT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.

Account